Our Reports
Automotive Reports Electronics & Semiconductor Telecom & IT Technology & IT Consumer Goods Healthcare Food & Beverages Chemical
Our Links
About Us Contact Us Press Release News Our Blogs

Int'l : +1(646) 600-5072 | query@kbvresearch.com


The Global Aspiration & Biopsy Needles Market is Estimated to reach $1.3 Billion by 2028, at a CAGR of 6.1%

Special Offering :

Industry Insights | Market Trends | Highest number of Tables | 24/7 Analyst Support

Aspiration & Biopsy Needles Market Growth, Trends and Report Highlights

According to a new report, published by KBV research, The Global Aspiration & Biopsy Needles Market size is expected to reach $1.3 billion by 2028, rising at a Market growth of 6.1% CAGR during the forecast period.

The Biopsy Needles segment acquired maximum share in the Global Aspiration & Biopsy Needles Market by Product Type in 2021, thereby, achieving a Market value of $858.5 million by 2028. This is due to an increase in the occurrence of cancer and a preference for the least intrusive diagnostic treatments (over excision biopsies). Following strategically created 3 mm incisions and the meticulous needle advancement approach with numerous images, a biopsy needle is a practical way to commence a kyphoplasty.).

The Non image-guided segment is showcasing a CAGR of 8.8% during (2022 - 2028). The injection of O2-O3 mixture is aimed in the muscular paravertebral tissues localized at the level of pathologic intersomatic space in non-image guided procedures.

The Hospitals & surgical centers segment is leading the Global Aspiration & Biopsy Needles Market by End User in 2021, thereby, achieving a Market value of $739.2 million by 2028. This is owing to the expanding number of hospitals in emerging countries and the strong preference for hospital-based biopsy procedures. In hospitals and surgical centers, one of the most prevalent purposes for an aspiration and biopsy needle is to determine a patient's condition. For example, if a person has been experiencing pain or discomfort and doctors are unable to pinpoint the source, they will use this sort of needle to obtain samples from various places of the body in order to conduct testing and establish the specific cause

The Wound Applications segment has shown growth rate of 6.3% during (2022 - 2028). Wounds occur frequently among children and adults due to them being active and getting hurt in sporting and other activities. Aspiration and biopsy needles are used in the cure of various wounds and thus, its demand is witnessing a significant rise in the Market .

The North America is the fastest growing region in the Global Aspiration & Biopsy Needles Market by Region in 2021, and would continue to be a dominant Market till 2028; thereby, achieving a Market value of $463.8 million by 2028. The Europe Market is estimated to witness a CAGR of 5.5% during (2022 - 2028). Additionally, The Asia Pacific Market would display a CAGR of 7.1% during (2022 - 2028).

Full Report: https://www.kbvresearch.com/aspiration-biopsy-needles-market/

The Market research report has exhaustive quantitative insights providing a clear picture of the Market potential in various segments across the globe with country wise analysis in each discussed region. The key impacting factors of the Market have been discussed in the report with the elaborated company profiles of Boston Scientific Corporation, Medtronic PLC, Johnson & Johnson, Merit Medical Systems, Inc., Cardinal Health, Inc., Becton, Dickinson and Company, ConMed Corporation, Olympus Corporation, Argon Medical Devices, Inc., and Cook Medical, Inc.

Global Aspiration & Biopsy Needles Market Segmentation

By Product Type

  • Biopsy Needles
  • Aspiration Needles

By Procedure

  • Image-guided
    • Ultrasound-guided
    • CT-guided
    • MRI-guided
    • Stereotactic
    • Others
  • Nonimage-guided

By End User

  • Hospitals & surgical centers
  • Diagnostic Clinics & pathology laboratories
  • Ambulatory care centers
  • Research & Academic Institutes

By Application

  • Tumor/ Cancer Applications
    • Breast Cancer
    • Lung Cancer
    • Colorectal Cancer
    • Prostate Cancer
    • Kidney Cancer
    • Bone & Bone Marrow Cancer
    • Others
  • Wound Applications
  • Others

By Geography

  • North America
    • US
    • Canada
    • Mexico
    • Rest of North America
  • Europe
    • Germany
    • UK
    • France
    • Russia
    • Spain
    • Italy
    • Rest of Europe
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Singapore
    • Malaysia
    • Rest of Asia Pacific
  • LAMEA
    • Brazil
    • Argentina
    • UAE
    • Saudi Arabia
    • South Africa
    • Nigeria
    • Rest of LAMEA

Companies Profiled

  • Boston Scientific Corporation
  • Medtronic PLC
  • Johnson & Johnson
  • Merit Medical Systems, Inc.
  • Cardinal Health, Inc.
  • Becton, Dickinson and Company
  • ConMed Corporation
  • Olympus Corporation
  • Argon Medical Devices, Inc.
  • Cook Medical, Inc.

Related Reports:



SUBSCRIPTION MODEL